SLC7A11 and central nervous system cancer: Moreover, abnormal expression of SLC7A11, regulated by IR, has been reported recently; high expression was found to correspond to poor survival in patients diagnosed with glioma, whereas SLC7A11 methylation indicated increased overall survival and disease-free survival.